Introduction
Flour has been forti®ed with iron in Sweden since 1944. Since 1970 the level has been 6.5 mg/100 g¯our. An early estimation suggested that about 42% of the total dietary iron intake comes from forti®cation of¯our (Westin, 1975) . Carbonyl iron which has been used in recent years has good properties according to animal studies, but a rather poor bioavailability according to studies in man (Hallberg et al, 1986) .
On 1st January 1995 the voluntary forti®cation was withdrawn. During the 50 y period of iron forti®cation food habits had improved. The use of preventive pills in females had resulted in reduced menstrual iron losses. The effect of iron forti®cation upon target groups such as females with large menstruations and female adolescents with poor dietary habits was considered to be uncertain. There are also possible hazards involved of a general forti®cation upon groups who do not need extra iron. People with iron loading genes might suffer if the iron content of their food is increased (Finch & Finch, 1955) .
Epidemiologic studies are ongoing to evaluate the effect of the reduced iron content of food for target groups such as adolescents and menstruating females. Results are expected within 2±4 y.
We wanted to know if an effect could be detected earlier in people with genetic hemochromatosis (GH) on regular phlebotomy following iron depletion. The method is simple, ®rst used by Whipple et al, 1925 and then modi®ed by Finch et al, 1950 . The iron loss following a quantitated bleeding is compensated by an equal amount of iron absorbed in a person with depleted iron stores. If available iron in the diet is reduced the donor can not be bled as often. We here compare the amount of iron absorbed during a period of iron forti®cation with that without forti®cation.
Material and methods
The donors There were 16 men aged 24±73 y on a phlebotomy program following iron depletion. Maintenance phlebotomy was adjusted to avoid replenishment of iron stores, avoiding a fully saturated transferrin (TS) without inducing anemia. They all had genetic hemochromatosis con®rmed by liver biopsy in all cases except one, a 25 y old blood donor detected to have a serum ferritin (SF) concentration of 622 mg/l and a transferrin saturation (TS) of 90% at another hospital in which increased liver iron stores was shown by the use of magnetic resonance imaging (MRI). The clinical expression of iron overload was most often mild. Only one subject had the advanced disease with diabetes and liver cirrhosis. Six were detected at investigation of abnormal liver tests, three at family screenings and six at screening of blood donors. Three of them had been regular blood donors for many years before the diagnosis.
Ten were accepted as blood donors and were bled at the blood bank. Six were bled at the out patient service of the present hospital.
Dietary intake
At diagnosis the men being studied had been advised to maintain an ordinary diet but to avoid liver and products such as blood pudding. At start of the present study a dietitian gave detailed instructions how to make a 7 d record during a week. Energy and nutrient intakes were calculated by the aid of a data bank compiled by the Swedish National Food Administration. A repeat interview was done after the end of the study, most often including the wives of the men.
The study design After depletion of iron stores a strict phlebotomy program was started, with measurement of Hb, TS and SF at each donation. An illustrative case is seen in Figure 1 showing changes in iron parameters in subject number nine. He was detected at a health check in 1989, at the age of 46, with slightly abnormal liver tests. SF was 1850 mg/l, the TS was 92%. Liver biopsy showed heavy iron overload but no ®brosis. He was still healthy and was accepted as blood donor at the blood bank. By weekly phlebotomy for one year, 11.7 g of iron was removed from his iron stores. Liver tests were reversed to normal. 
The second study period (C±D)
The second study period started seven months later, at C, when the diet was no longer forti®ed. The intervals between the donations had now to be extended to avoid iron de®ciency anemia. The average SF concentration, 11 mg/l, was lower than during the ®rst study period, 20 mg/l. The quantity of iron removed during 510 d between C and D was 1844 mg corresponding to a daily iron absorption of 3.8 mg from the non forti®ed diet.
One donor, number 13, had a constant moderate iron de®ciency anemia throughout the study. He had been advised not to donate as often, however he preferred the present schedule because he felt well. It had made him free from abdominal discomfort for more than 10 y being a problem for him before the time of diagnosis and start of therapy in 1979. The fact that an uncle had died from the disease was perhaps an additional argument. One donor had to be excluded because of a sarcoidosis appearing during the study period. Treatment with corticosteroids and acetylsalicylates had to be instituted. One donor, number 2, was treated with¯ucloxacillin for two weeks in 1993 for a wound infection and got a drug induced cholestatic liver reaction. He could soon resume his phlebotomies and he was not excluded. Donor number 14 was investigated because of slowly falling Hb values 1992±1994 after 4 y on regular phlebotomy. He had no symptoms, no weight loss. X ray series of his colon was negative, so also a rectoscopy and a gastroscopy. There were no signs of malabsorption. Antibodies against gliadin and endomysium were absent. When the intervals between the donations were increased, he resumed normal Hb levels.
Methods
Hb was measured in an automatic Sysmec SE 9000 (Toa Medical Electronics, Kobe, Japan). Serum iron and total iron binding capacity (TIBC) were analyzed using the Technicon Axon TM system (Technicon Instruments Corp., Tarrytown, NY, USA). Serum ferritin was analyzed with an immunochemical method (Abbott Laboratories, Abbott Park, IL, USA). The volume of blood taken at the blood bank was 0.48 l including blood samples. The corresponding volumes were 0.41 or 0.51 l taken at the out patient service of the hospital. The Hb concentration was measured on venous blood taken at the end of each phlebotomy.
The study was approved by the Ethical Committee, University of Go Èteborg.
Statistics
Descriptive statistics and paired t-test were used with the aid of a computer program (Abacus Concepts, Statview, Berkeley, CA, 1992). A difference was considered signi®-cant at P`0.05.
Results
After iron depletion the donors had been on maintenance phlebotomy for a mean of 5.3 y before the start of the present study, at A (Figure 1) . The results are summarised in Tables 1 and 2 and Figures 1 and 2 . Tables 1 and 2 show that the Hb concentration, the transferrin saturation and the serum ferritin concentration at the beginning and the end of the two study periods were not signi®cantly different and therefore comparable. The ®rst study period (A±B) comprised 544 AE 146 d. The amount of iron absorbed necessary to compensate for the blood loss induced was 4.27 AE 1.2 mg/d. The second study period (C±D) comprising 500 AE 85 d, started seven months later when food was no longer forti®ed. There was now a signi®cant reduction of the amount of iron absorbed to a mean of 3.63 AE 1.1 mg/d. This period was characterised by a more intense iron depletion (Figure 1 ) despite a signi®cant extension of the intervals between donations, from 59 AE 15 to 69 AE 17 d (P`0.01). The average SF concentration between C and D was 14.2 AE 4 mg/l, which was signi®cantly lower (P`0.03) than that of the ®rst study period, 21.2 AE 12 mg/l (®gures not given in Table 1 ).
There was a signi®cant correlation between iron absorption values during the two study periods, r 2 0.78, however, 14 of the 15 donors had a lower iron absorption when the diet was no longer forti®ed, (Figure 2 ). If we include the quantity of iron absorbed to cover basal iron losses (14 mg/ kg/d) the total amount of iron absorbed from the forti®ed diet will be 5.43 AE 1.32 mg/d and 4.79 AE 1.2 mg/d from the non forti®ed diet. The difference of iron absorbed of 0.65 (95% c.i. 0.32±0.97) mg per day was highly signi®cant (P`0.002), and was considered equal to the amount of iron that is derived from carbonyl iron used as forti®cant. This fraction amounts to 12% of the total amount of iron absorbed from the forti®ed diet.
There were no signs indicating a progressive decline in iron absorption with time. In donor number 2, iron absorption was measured at three intervals during six years of maintenance phlebotomy. He had an almost constant iron absorption of 4.8, 4.6 and 4.8 mg/d from the forti®ed diet. When food was no longer forti®ed, iron absorption was reduced to 3.8 mg/d (Table 1) .
From dietary interviews the iron content of the forti®ed diet averaged 15.4 mg/d and the forti®ed fraction was estimated to 4.1 mg/d or 27%. There was no indication of a change of the dietary habits during the study. However two men (numbers 9 and 13, Table 1) admitted that they had tried to reduce the intake of red meat, two (numbers 4 and 11, father and son) on the other hand declared that they might have had an increase in meat consumption during the study period. Ten con®rmed that they had not changed their dietary habits. None had changed drinking habits, (milk, wine, juice).
The relative bioavailability of carbonyl iron used as forti®cant was calculated according to Hallberg et al, 1986 . The total amount of iron absorbed from the non forti®ed diet (15.4±4.1) of 11.3 mg was 4.79 mg or 42%. If the same percentage is absorbed from the available fraction of the forti®ed diet, its relative bioavailability (b) can be Figure 2 Scattergram showing a signi®cant (r 2 0.78) relationship between iron absorption to compensate blood loss during a period of iron forti®cation (A±B) with that without forti®cation (C±D). The identity line (dotted) shows that 14 of the 15 (93%) had a lower iron absorption, when the diet was no longer forti®ed. No correlation was found between the iron content of the diet and the amount of iron absorbed (Table 1) . A relationship between the daily iron absorption and the size of the initial iron stores was hard to demonstrate, because results of iron storage was missing in two donors and affected by previous blood donations in further three subjects.
Discussion
When Sweden decided to stop the iron forti®cation of food from 1st January 1995 it was a big step, because no other country in the world had forti®ed its food as heavily as Sweden. The effect of such an experiment will be carefully studied in coming years when the main target groups such as adolescents and menstruating females have used the new non forti®ed diet. We wanted to study if an effect could be seen earlier by using the information gained from a selected group of males on maintenance phlebotomy because of genetic iron overload. There is no general agreement regarding the intensity of maintenance treatment in people with GH (Adams et al, 1993) . We have used a strict schedule to avoid a fully saturated transferrin. This can be accomplished by keeping the iron stores almost depleted. This more intensive program has been accepted for many years by the majority of the donors and has also been recommended in recent reviews (Powell et al, 1994) . The fact that the blood has been accepted for transfusions in most of the donors might have facilitated such a program.
The method of quantitated phlebotomy is simple. The quantity of hemoglobin that can be removed is dependent of the capacity of the gut to absorb iron from the diet for Hb synthesis. In the present study two diets were tested, one with forti®cation, the other without. Some prerequisites have to be ful®lled. There should be no other losses of iron such as bleedings from the gastrointestinal tract. The majority of the present men were healthy and accepted as full blood donors. However ®ve had an occasional intake of non steroid antiin¯ammatory drugs because of arthropathy. Such medication might induce bleedings from the gastric mucosa. None had, however, gastrointestinal complaints. None took antacids. They were not excluded.
Prolonged in¯ammatory conditions might reduce iron absorption. One of the donors was therefore excluded because of a sarcoidosis. The food intake or dietary habits should be the same. Two donors admitted to a reduction of the intake of red meat during the study period. Two others had a possible increase in meat consumption. However the majority ®rmly declared that they had not changed their dietary or drinking habits. There should be no residual iron stores left after the initial iron depletion. In this study there was an average period of 5.3 y between the end of initial iron removal and the start of the present study. The iron status should be kept constant. In the present study, however, the SF concentration was signi®cantly lower during the second study period, indicating more depleted iron stores. This might give an extra stimulus to the erythron and an increase of iron absorption from the gut (Cook et al, 1974; Bezwoda et al, 1981) .
Despite this stimulus there was a signi®cant (P`0.001) reduction of iron absorbed during the second study period when food was no longer forti®ed. The difference of 0.65 mg/d (c.i. 0.32±0.97) was considered equal to the amount of iron that was derived from iron forti®cation. The present results showing a mean iron absorption of 4.3 mg/d was similar to those obtained in normal men, 3.8 mg/d, bled to a moderate iron de®ciency anemia and studied by Hb regeneration (Olszon et al, 1978) .
There was no relationship between the iron content of the forti®ed diet and the amount of iron absorbed. Most of this iron is consumed as bread. Several factors affects its bioavailability, such as the composition of the meal with which the bread is eaten (Hallberg et al, 1986) . These factors may explain why studies also using very carefully obtained dietary records have been unable to show a relationship between iron absorption and the iron content of the diet (Olszon et al, 1978) .
In the present study the dietary iron content averaged 15.4 mg/d. This ®gure is probably too low because the present method of dietary record will often underestimate the true iron content of the diet (Livingstone et al, 1990; Hallberg & Rossander-Hulte Ân, 1991) . There are also dif®-culties to measure the fraction of iron that comes from forti®cation. In the present study the forti®ed fraction was estimated to 27% which is lower than in the ®rst report by Westin, 1975 , but higher than in two more recent estimations, 20 and 25% (Olszon et al, 1978; Hallberg & Rossander-Hulte Ân, 1991) . If the true iron content was 18 mg/d and the forti®cation fraction constitutes 27%, the relative bioavailability of carbonyl iron would be 30%. Even in view of this uncertainty it seems as if the bioavailability of carbonyl used as forti®cant of the diet is better than in a previous report based on isotopic studies of single meals (Hallberg et al, 1986) .
The present results may therefore support earlier estimations showing iron forti®cation as one of the major factors contributing to the reduction of iron de®ciency anemia in Swedish women (Hallberg et al, 1979; Bothwell & Charlton, 1982) . Our results can, however, not easily be translated to this target group. The dietary habits might differ and also the energy (and iron) intake with lower ®gures in females.
The design of the present study with intermittent blood loss through phlebotomy can be expected to activate the erythron regulator and give an extra stimulus to iron absorption (Bezwoda et al, 1981; Finch, 1994) . More iron may thereby be extracted also from sparsely available dietary iron sources such as forti®cation iron through such a mechanism. The relative bioavailability of carbonyl iron might be`falsely' high through such a mechanism.
It seems, however, reasonable to assume that females balancing at the border of iron de®ciency because of heavy menstrual iron losses will be affected by the reduced iron content of the Swedish diet. In that regard recent observations from two Swedish Blood Banks are of considerable interest.
Female blood donors in Umea Ê, Sweden followed by serial determinations of SF for years have shown a signi®cant drop in SF concentration 1996, the year when the full effect of iron forti®cation withdrawal is present. (Axelsson CG, personal communication) . Similar observations were reported from the Blood Bank of the University Hospital in Linko Èping (Lieden G, personal communication).
The present results would indicate that men with genetic hemochromatosis on a forti®ed diet as that used in Sweden will increase their iron load by 12%. However, this ®gure can not be used as a measure of the total effect of iron forti®cation on iron stores in patients with GH, because the present results are relevant only to the early onset of the disease (Bezwoda et al, 1981; Bothwell & Charlton, 1982) .
There has been no indication of a more severe iron loading of people with GH in Sweden. On the contrary storage iron in this category is on the average lower than in many countries (Olsson et al, 1988) . This is probably the result of dietary differences with lower intake of meat and vegetables, factors that explain the higher prevalence also of iron de®ciency in Northern Scandinavia (Hallberg & Rossander Hulte Ân, 1991) .
Conclusion
The present results indicate that the bioavailability of carbonyl iron used as forti®cant in Sweden might be better than reported. The withdrawal of iron forti®cation will probably result in an increase in the prevalence of iron de®ciency in target groups such as menstruating females. People being homozygous for iron loading genes might on the other hand start accumulating excess iron more slowly in the future, when the diet is no longer forti®ed.
